https://www.reveal-genomics.com/es https://www.reveal-genomics.com https://www.reveal-genomics.com/es/blog https://www.reveal-genomics.com/blog https://www.reveal-genomics.com/es/contact https://www.reveal-genomics.com/contact https://www.reveal-genomics.com/es/her2dx https://www.reveal-genomics.com/her2dx https://www.reveal-genomics.com/es/investors https://www.reveal-genomics.com/investors https://www.reveal-genomics.com/es/leadership https://www.reveal-genomics.com/leadership https://www.reveal-genomics.com/es/legal-notice https://www.reveal-genomics.com/legal-notice https://www.reveal-genomics.com/es/news https://www.reveal-genomics.com/news https://www.reveal-genomics.com/es/news-and-publications https://www.reveal-genomics.com/news-and-publications https://www.reveal-genomics.com/es/our-approach https://www.reveal-genomics.com/our-approach https://www.reveal-genomics.com/es/privacy-policy https://www.reveal-genomics.com/privacy-policy https://www.reveal-genomics.com/es/cookie-policy https://www.reveal-genomics.com/cookie-policy https://www.reveal-genomics.com/es/log-in https://www.reveal-genomics.com/log-in https://www.reveal-genomics.com/es/sign-up https://www.reveal-genomics.com/sign-up https://www.reveal-genomics.com/es/reset-password https://www.reveal-genomics.com/reset-password https://www.reveal-genomics.com/es/update-password https://www.reveal-genomics.com/update-password https://www.reveal-genomics.com/es/access-denied https://www.reveal-genomics.com/access-denied https://www.reveal-genomics.com/es/user-account https://www.reveal-genomics.com/user-account https://www.reveal-genomics.com/es/search https://www.reveal-genomics.com/search https://www.reveal-genomics.com/es/dnadx https://www.reveal-genomics.com/dnadx https://www.reveal-genomics.com/es/quality-policy https://www.reveal-genomics.com/quality-policy https://www.reveal-genomics.com/es/instructions-for-sending-samples https://www.reveal-genomics.com/instructions-for-sending-samples https://www.reveal-genomics.com/es/tnbcdx https://www.reveal-genomics.com/tnbcdx https://www.reveal-genomics.com/es/security-policy https://www.reveal-genomics.com/security-policy https://www.reveal-genomics.com/es/privacy-policy-es https://www.reveal-genomics.com/privacy-policy-es https://www.reveal-genomics.com/es/dnadx-instructions-for-sending-samples- https://www.reveal-genomics.com/dnadx-instructions-for-sending-samples- https://www.reveal-genomics.com/es/patients https://www.reveal-genomics.com/patients https://www.reveal-genomics.com/blog-post/as-an-oncologist-what-i-want-is-for-these-instruments-to-be-available-for-use-in-our-practices https://www.reveal-genomics.com/es/blog-post/as-an-oncologist-what-i-want-is-for-these-instruments-to-be-available-for-use-in-our-practices https://www.reveal-genomics.com/blog-post/genomic-assay-changes-minds-on-her2-bc-treatment https://www.reveal-genomics.com/es/blog-post/genomic-assay-changes-minds-on-her2-bc-treatment https://www.reveal-genomics.com/blog-post/investigadores-del-clinic-y-el-vall-dhebron-crean-la-biotecnologica-reveal-genomics https://www.reveal-genomics.com/es/blog-post/investigadores-del-clinic-y-el-vall-dhebron-crean-la-biotecnologica-reveal-genomics https://www.reveal-genomics.com/blog-post/investigadores-se-une-para-la-deteccion-precoz-del-cancer-de-mama- https://www.reveal-genomics.com/es/blog-post/investigadores-se-une-para-la-deteccion-precoz-del-cancer-de-mama- https://www.reveal-genomics.com/blog-post/many-more-role-models-are-needed-womens-presence-in-the-catalan-biomedical-ecosystem https://www.reveal-genomics.com/es/blog-post/many-more-role-models-are-needed-womens-presence-in-the-catalan-biomedical-ecosystem https://www.reveal-genomics.com/blog-post/reveal-genomics-dana-farber-using-her2dx-to-analyze-data-in-three-breast-cancer-trials https://www.reveal-genomics.com/es/blog-post/reveal-genomics-dana-farber-using-her2dx-to-analyze-data-in-three-breast-cancer-trials https://www.reveal-genomics.com/blog-post/reveal-genomics-ficha-en-solti-a-su-nueva-consejera-delegada https://www.reveal-genomics.com/es/blog-post/reveal-genomics-ficha-en-solti-a-su-nueva-consejera-delegada https://www.reveal-genomics.com/blog-post/reveal-genomics-introduces-her2dx-breast-cancer-test-in-europe-plans-us-expansion https://www.reveal-genomics.com/es/blog-post/reveal-genomics-introduces-her2dx-breast-cancer-test-in-europe-plans-us-expansion https://www.reveal-genomics.com/blog-post/reveal-genomics-r-breakthrough-technology-enters-the-liquid-biopsy-field-in-oncology https://www.reveal-genomics.com/es/blog-post/reveal-genomics-r-breakthrough-technology-enters-the-liquid-biopsy-field-in-oncology https://www.reveal-genomics.com/blog-post/sabcs23-reveal-genomics-r-unleashes-groundbreaking-dnadx-r-liquid-biopsy-data-for-metastatic-breast-cancer https://www.reveal-genomics.com/es/blog-post/sabcs23-reveal-genomics-r-unleashes-groundbreaking-dnadx-r-liquid-biopsy-data-for-metastatic-breast-cancer https://www.reveal-genomics.com/blog-post/spanish-startup-aims-to-develop-genomic-tests-to-guide-breast-cancer-treatments https://www.reveal-genomics.com/es/blog-post/spanish-startup-aims-to-develop-genomic-tests-to-guide-breast-cancer-treatments https://www.reveal-genomics.com/blog-post/the-best-inventions-of-2022-personalized-breast-cancer-care-reveal-genomics-her2dx-test https://www.reveal-genomics.com/es/blog-post/the-best-inventions-of-2022-personalized-breast-cancer-care-reveal-genomics-her2dx-test https://www.reveal-genomics.com/blog-post/un-test-genomico-mejora-el-tratamiento-de-uno-de-cada-cinco-canceres-de-mama https://www.reveal-genomics.com/es/blog-post/un-test-genomico-mejora-el-tratamiento-de-uno-de-cada-cinco-canceres-de-mama https://www.reveal-genomics.com/team/charles-perou https://www.reveal-genomics.com/es/team/charles-perou https://www.reveal-genomics.com/press-releases/alianza-estrategica-entre-medsir-y-reveal-genomics-r-para-investigar-contra-el-cancer https://www.reveal-genomics.com/es/press-releases/alianza-estrategica-entre-medsir-y-reveal-genomics-r-para-investigar-contra-el-cancer https://www.reveal-genomics.com/press-releases/asco-2025-reveal-genomics-unveils-new-her2dx-data-from-800-patients https://www.reveal-genomics.com/press-releases/esmo-2022-reveal-genomics-r-presents-new-validation-data-of-her2dx-r-in-the-perelisa-trial https://www.reveal-genomics.com/es/press-releases/esmo-2022-reveal-genomics-r-presents-new-validation-data-of-her2dx-r-in-the-perelisa-trial https://www.reveal-genomics.com/press-releases/first-clinical-impact-data-of-her2dx-r-according-to-two-independent-studies-presented-at-the-seom-congress https://www.reveal-genomics.com/es/press-releases/first-clinical-impact-data-of-her2dx-r-according-to-two-independent-studies-presented-at-the-seom-congress https://www.reveal-genomics.com/press-releases/groundbreaking-study-confirms-clinical-decision-impact-of-her2dx-r-genomic-assay-in-early-stage-her2-positive-breast-cancer https://www.reveal-genomics.com/press-releases/her2dx-first-genomic-test-for-personalized-her2-breast-cancer-treatments https://www.reveal-genomics.com/es/press-releases/her2dx-first-genomic-test-for-personalized-her2-breast-cancer-treatments https://www.reveal-genomics.com/press-releases/her2dx-r-recognized-by-time-as-one-of-the-best-inventions-of-2022 https://www.reveal-genomics.com/es/press-releases/her2dx-r-recognized-by-time-as-one-of-the-best-inventions-of-2022 https://www.reveal-genomics.com/press-releases/meta-analysis-in-the-lancet-oncology-validates-her2dx-prognostic-value-in-early-her2-positive-breast-cancer https://www.reveal-genomics.com/es/press-releases/meta-analysis-in-the-lancet-oncology-validates-her2dx-prognostic-value-in-early-her2-positive-breast-cancer https://www.reveal-genomics.com/press-releases/nature-communications-study-supports-her2dx-as-a-genomic-tool-for-tailored-therapy-in-older-individuals-with-her2-breast-cancer https://www.reveal-genomics.com/es/press-releases/nature-communications-study-supports-her2dx-as-a-genomic-tool-for-tailored-therapy-in-older-individuals-with-her2-breast-cancer https://www.reveal-genomics.com/press-releases/our-cso-and-co-founder-dr-aleix-prat-has-been-awarded-the-national-research-award-doctores-diz-pintado-for-his-work-that-is-now-part-of-our-company https://www.reveal-genomics.com/es/press-releases/our-cso-and-co-founder-dr-aleix-prat-has-been-awarded-the-national-research-award-doctores-diz-pintado-for-his-work-that-is-now-part-of-our-company https://www.reveal-genomics.com/press-releases/primeros-datos-de-impacto-clinico-del-her2dx-r-segun-dos-estudios-independientes-presentados-en-el-congreso-de-la-seom https://www.reveal-genomics.com/es/press-releases/primeros-datos-de-impacto-clinico-del-her2dx-r-segun-dos-estudios-independientes-presentados-en-el-congreso-de-la-seom https://www.reveal-genomics.com/press-releases/reveal-genomics-achieves-iso-13485-2016-certification-for-its-quality-management-system https://www.reveal-genomics.com/es/press-releases/reveal-genomics-achieves-iso-13485-2016-certification-for-its-quality-management-system https://www.reveal-genomics.com/press-releases/reveal-genomics-aligns-founder-leadership-with-priorities-to-support-long-term-growth-scientific-excellence-and-global-partnerships https://www.reveal-genomics.com/es/press-releases/reveal-genomics-aligns-founder-leadership-with-priorities-to-support-long-term-growth-scientific-excellence-and-global-partnerships https://www.reveal-genomics.com/press-releases/reveal-genomics-and-ona-therapeutics-join-forces-to-advance-next-generation-cancer-treatment https://www.reveal-genomics.com/press-releases/reveal-genomics-announces-research-collaboration-in-her2-breast-cancer https://www.reveal-genomics.com/es/press-releases/reveal-genomics-announces-research-collaboration-in-her2-breast-cancer https://www.reveal-genomics.com/press-releases/reveal-genomics-appoints-patricia-villagrasa-gonzalez-as-new-ceo https://www.reveal-genomics.com/es/press-releases/reveal-genomics-appoints-patricia-villagrasa-gonzalez-as-new-ceo https://www.reveal-genomics.com/press-releases/reveal-genomics-i-avancsa-signen-un-acord-estrategic-per-impulsar-el-creixement-i-la-internacionalitzacio-de-la-companyia https://www.reveal-genomics.com/es/press-releases/reveal-genomics-i-avancsa-signen-un-acord-estrategic-per-impulsar-el-creixement-i-la-internacionalitzacio-de-la-companyia https://www.reveal-genomics.com/press-releases/reveal-genomics-presents-the-latest-her2dx-r-data-in-her2-breast-cancer-at-sabcs-2022 https://www.reveal-genomics.com/es/press-releases/reveal-genomics-presents-the-latest-her2dx-r-data-in-her2-breast-cancer-at-sabcs-2022 https://www.reveal-genomics.com/press-releases/reveal-genomics-r-and-the-istituto-europeo-di-oncologia-ieo-collaborate-on-a-groundbreaking-her2dx-r-test-decision-impact-study https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-and-the-istituto-europeo-di-oncologia-ieo-collaborate-on-a-groundbreaking-her2dx-r-test-decision-impact-study https://www.reveal-genomics.com/press-releases/reveal-genomics-r-announces-positive-top-line-results-for-her2dx-r-in-apt-and-atempt-trials https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-announces-positive-top-line-results-for-her2dx-r-in-apt-and-atempt-trials https://www.reveal-genomics.com/press-releases/reveal-genomics-r-announces-positive-top-line-results-for-her2dx-r-in-cleopatra-phase-iii-trial https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-announces-positive-top-line-results-for-her2dx-r-in-cleopatra-phase-iii-trial https://www.reveal-genomics.com/press-releases/reveal-genomics-r-announces-positive-top-line-results-for-her2dx-r-in-medsirs-phergain-trial https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-announces-positive-top-line-results-for-her2dx-r-in-medsirs-phergain-trial https://www.reveal-genomics.com/press-releases/reveal-genomics-r-anuncia-la-inclusion-de-su-test-her2dx-r-en-las-guias-clinicas-seom-para-cancer-de-mama-her2-en-estadios-iniciales https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-anuncia-la-inclusion-de-su-test-her2dx-r-en-las-guias-clinicas-seom-para-cancer-de-mama-her2-en-estadios-iniciales https://www.reveal-genomics.com/press-releases/reveal-genomics-r-breakthrough-technology-enters-the-liquid-biopsy-field-in-oncology https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-breakthrough-technology-enters-the-liquid-biopsy-field-in-oncology https://www.reveal-genomics.com/press-releases/reveal-genomics-r-her2dx-r-genomic-test-demonstrates-significant-potential-in-her2-positive-advanced-gastric-cancer https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-her2dx-r-genomic-test-demonstrates-significant-potential-in-her2-positive-advanced-gastric-cancer https://www.reveal-genomics.com/press-releases/reveal-genomics-r-her2dx-r-genomic-test-to-be-validated-in-pivotal-ecog-acrin-compassher2-pcr-trial-in-her2-breast-cancer https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-her2dx-r-genomic-test-to-be-validated-in-pivotal-ecog-acrin-compassher2-pcr-trial-in-her2-breast-cancer https://www.reveal-genomics.com/press-releases/reveal-genomics-r-her2dx-r-genomic-test-to-undergo-first-prospective-trial-as-part-of-the-definitive-project-funded-by-the-european-commission https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-her2dx-r-genomic-test-to-undergo-first-prospective-trial-as-part-of-the-definitive-project-funded-by-the-european-commission https://www.reveal-genomics.com/press-releases/reveal-genomics-r-links-immune-tumor-response-to-longevity-in-breast-cancer-survivors https://www.reveal-genomics.com/press-releases/reveal-genomics-r-markets-her2dx-r-the-worlds-first-genomic-test-for-personalized-her2-breast-cancer-treatment https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-markets-her2dx-r-the-worlds-first-genomic-test-for-personalized-her2-breast-cancer-treatment https://www.reveal-genomics.com/press-releases/reveal-genomics-r-to-evaluate-prospective-real-time-performance-of-her2dx-r-genomic-test-in-the-united-states https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-to-evaluate-prospective-real-time-performance-of-her2dx-r-genomic-test-in-the-united-states https://www.reveal-genomics.com/press-releases/reveal-genomics-r-unveils-tnbcdx-r-the-first-genomic-test-designed-for-early-stage-triple-negative-breast-cancer https://www.reveal-genomics.com/es/press-releases/reveal-genomics-r-unveils-tnbcdx-r-the-first-genomic-test-designed-for-early-stage-triple-negative-breast-cancer https://www.reveal-genomics.com/press-releases/reveal-genomics-y-hm-hospitales-firman-un-acuerdo-para-ofrecer-el-test-genomico-her2dx-r-en-su-portfolio https://www.reveal-genomics.com/es/press-releases/reveal-genomics-y-hm-hospitales-firman-un-acuerdo-para-ofrecer-el-test-genomico-her2dx-r-en-su-portfolio https://www.reveal-genomics.com/press-releases/sabcs-2025-reveal-genomics-presents-major-advance-in-predicting-brain-metastasis-in-her2-breast-cancer https://www.reveal-genomics.com/es/press-releases/sabcs-2025-reveal-genomics-presents-major-advance-in-predicting-brain-metastasis-in-her2-breast-cancer https://www.reveal-genomics.com/press-releases/sabcs23-reveal-genomics-r-unleashes-groundbreaking-dnadx-r-liquid-biopsy-data-for-metastatic-breast-cancer https://www.reveal-genomics.com/es/press-releases/sabcs23-reveal-genomics-r-unleashes-groundbreaking-dnadx-r-liquid-biopsy-data-for-metastatic-breast-cancer https://www.reveal-genomics.com/press-releases/spin-off-reveal-genomics-emerges-to-develop-innovative-diagnostic-tests-in-oncology https://www.reveal-genomics.com/es/press-releases/spin-off-reveal-genomics-emerges-to-develop-innovative-diagnostic-tests-in-oncology https://www.reveal-genomics.com/press-releases/strategic-partnership-between-medsir-and-reveal-genomics-r-for-cancer-research https://www.reveal-genomics.com/es/press-releases/strategic-partnership-between-medsir-and-reveal-genomics-r-for-cancer-research https://www.reveal-genomics.com/press-releases/study-links-reveal-genomics-assays-her2dx-and-dnadx-to-response-to-trastuzumab-deruxtecan-in-metastatic-breast-cancer https://www.reveal-genomics.com/es/press-releases/study-links-reveal-genomics-assays-her2dx-and-dnadx-to-response-to-trastuzumab-deruxtecan-in-metastatic-breast-cancer https://www.reveal-genomics.com/news/a-new-approach-to-physicians-and-patients https://www.reveal-genomics.com/es/news/a-new-approach-to-physicians-and-patients https://www.reveal-genomics.com/news/reveal-genomics-holds-annual-cycle-meeting-reinforcing-global-growth-strategy https://www.reveal-genomics.com/es/news/reveal-genomics-holds-annual-cycle-meeting-reinforcing-global-growth-strategy https://www.reveal-genomics.com/news/we-continue-to-gather-more-support-data-for-her2dx-r https://www.reveal-genomics.com/es/news/we-continue-to-gather-more-support-data-for-her2dx-r https://www.reveal-genomics.com/job-offers/bioinformatician-2025 https://www.reveal-genomics.com/es/job-offers/bioinformatician-2025